Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.14 HKD | -4.21% |
|
+6.23% | -44.08% |
11:26am | Cutia Therapeutics Enrolls Final Patient in Phase II Trial of Weight Loss Drug | MT |
28/06 | Cutia Therapeutics Announces Last Patient Enrollment in the Phase II Clinical Trial of Cu-20401 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.08% | 250M | |
+55.38% | 823B | |
+42.31% | 641B | |
-6.85% | 352B | |
+17.01% | 324B | |
+7.37% | 301B | |
+14.02% | 241B | |
+1.64% | 223B | |
+13.66% | 218B | |
+8.03% | 167B |
- Stock Market
- Equities
- 2487 Stock
- News Cutia Therapeutics
- Cutia Therapeutics' Revenue Up 123% in Q1